Donor pre-treatment in clinical kidney transplantation: A critical appraisal

Clinical Transplantation

Volumn 27, Issue 6, 2013, Pages 799-808

  de Vries, Dorottya K ^a   Wijermars, Leonie G M ^a   Reinders, Marlies E J ^a   Lindeman, Jan H N ^a   Schaapherder, Alexander F M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Brain death; Donor management; Donor pre treatment; Kidney transplantation

Indexed keywords

GRAFT SURVIVAL; HUMAN; ISCHEMIC PRECONDITIONING; KIDNEY DONOR; KIDNEY INJURY; KIDNEY TRANSPLANTATION; LIVING DONOR; PREMEDICATION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SURVIVAL;

BRAIN DEATH; DONOR MANAGEMENT; DONOR PRE-TREATMENT; KIDNEY TRANSPLANTATION;

GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; REPERFUSION INJURY; TISSUE DONORS;

EID: 84889085747     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12261     Document Type: Review

References (91)

1. McDonald SP, Russ GR. Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001. Nephrol Dial Transplant 2002: 17: 2212.
2. Schnuelle P, Lorenz D, Trede M, van der Woude FJ. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol 1998: 9: 2135.
3. Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993: 270: 1339.
4. Marcen R, Teruel JL. Patient outcomes after kidney allograft loss. Transplant Rev (Orlando) 2008: 22: 62.
5. Marcen R, Pascual J, Teruel JL et al. Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss? Transplantation 2001: 72: 57.
6. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004: 4: 1289.
7. Ravanan R, Udayaraj U, Steenkamp R, Ansell D. UK Renal Registry 11th Annual Report (December 2008): chapter 5 Demographics and biochemistry profile of kidney transplant recipients in the UK in 2007: national and centre-specific analyses. Nephron Clin Pract 2009: 111(Suppl. 1): c69.
8. Harper AM, Rosendale JD. The UNOS OPTN waiting list and donor registry: 1988-1996. Clin Transpl 1996:69.
9. Smith JM, Biggins SW, Haselby DG et al. Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant 2012: 12: 3191.
10. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995: 333: 333.
11. Pratschke J, Wilhelm MJ, Kusaka M, Hancock WW, Tilney NL. Acute rejection of rat renal allografts is accelerated by donor brain death. Transplant Proc 1999: 31: 874.
12. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995: 59: 565.
13. van der Woude FJ, Schnuelle P, Yard BA. Preconditioning strategies to limit graft immunogenicity and cold ischemic organ injury. J Investig Med 2004: 52: 323.
14. van der Hoeven JA, Molema G, Ter Horst GJ et al. Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 2003: 64: 1874.
15. Weiss S, Kotsch K, Francuski M et al. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 2007: 7: 1584.
16. Schuurs TA, Morariu AM, Ottens PJ et al. Time-dependent changes in donor brain death related processes. Am J Transplant 2006: 6: 2903.
17. de Vries DK, Lindeman JH, Ringers J et al. Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantation. Am J Transplant 2011: 11: 1064.
18. Rosendale JD, Chabalewski FL, McBride MA et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2002: 2: 761.
19. Audibert G, Charpentier C, Seguin-Devaux C et al. Improvement of donor myocardial function after treatment of autonomic storm during brain death. Transplantation 2006: 82: 1031.
20. Pennefather SH, Bullock RE, Dark JH. The effect of fluid therapy on alveolar arterial oxygen gradient in brain-dead organ donors. Transplantation 1993: 56: 1418.
21. Minambres E, Rodrigo E, Ballesteros MA et al. Impact of restrictive fluid balance focused to increase lung procurement on renal function after kidney transplantation. Nephrol Dial Transplant 2010: 25: 2352.
22. Rosendale JD, Kauffman HM, McBride MA et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003: 75: 482.
23. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986: 74: 1124.
24. Fuller TF, Freise CE, Feng S, Niemann CU. Ischemic preconditioning improves rat kidney graft function after severe ischemia/reperfusion injury. Transplant Proc 2005: 37: 377.
25. Jia RP, Xie JJ, Luo FY, Zhu JG. Ischemic preconditioning improves rat kidney allograft function after ischemia/reperfusion injury: the role of tumor necrosis factor-alpha. Transplant Proc 2008: 40: 3316.
26. Jia RP, Zhu JG, Wu JP, Xie JJ, Xu LW. Experimental study on early protective effect of ischemic preconditioning on rat kidney graft. Transplant Proc 2009: 41: 69.
27. Reutzel-Selke A, Pratschke J, Martins PN et al. Ischemic preconditioning produces systemic protective and adoptively transferable effects. Kidney Int 2008: 74: 622.
28. Grenz A, Osswald H, Eckle T et al. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med 2008: 5: e137.
29. Ogawa T, Nussler AK, Tuzuner E et al. Contribution of nitric oxide to the protective effects of ischemic preconditioning in ischemia-reperfused rat kidneys. J Lab Clin Med 2001: 138: 50.
30. Yamasowa H, Shimizu S, Inoue T, Takaoka M, Matsumura Y. Endothelial nitric oxide contributes to the renal protective effects of ischemic preconditioning. J Pharmacol Exp Ther 2005: 312: 153.
31. Kinsey GR, Huang L, Vergis AL, Li L, Okusa MD. Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int 2010: 77: 771.
32. Patschan D, Krupincza K, Patschan S et al. Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning. Am J Physiol Renal Physiol 2006: 291: F176.
33. Behrends M, Walz MK, Kribben A et al. No protection of the porcine kidney by ischaemic preconditioning. Exp Physiol 2000: 85: 819.
34. Kosieradzki M, Ametani M, Southard JH, Mangino MJ. Is ischemic preconditioning of the kidney clinically relevant? Surgery 2003: 133: 81.
35. Wever KE, Warle MC, Wagener FA et al. Remote ischaemic preconditioning by brief hind limb ischaemia protects against renal ischaemia-reperfusion injury: the role of adenosine. Nephrol Dial Transplant 2011: 26: 3108.
36. Kharbanda RK, Nielsen TT, Redington AN. Translation of remote ischaemic preconditioning into clinical practice. Lancet 2009: 374: 1557.
37. Salahudeen AK, Yang M, Huang H, Dore S, Stec DE. Fenoldopam preconditioning: role of heme oxygenase-1 in protecting human tubular cells and rodent kidneys against cold-hypoxic injury. Transplantation 2011: 91: 176.
38. Yard B, Beck G, Schnuelle P et al. Prevention of cold-preservation injury of cultured endothelial cells by catecholamines and related compounds. Am J Transplant 2004: 4: 22.
39. Gottmann U, Notheisen A, Brinkkoetter PT et al. Influence of donor pretreatment with dopamine on allogeneic kidney transplantation after prolonged cold storage in rats. Transplantation 2005: 79: 1344.
40. Liu Z, Hoeger S, Schnuelle P et al. Donor dopamine pretreatment inhibits tubulitis in renal allografts subjected to prolonged cold preservation. Transplantation 2007: 83: 297.
41. Gottmann U, Brinkkoetter PT, Bechtler M et al. Effect of pre-treatment with catecholamines on cold preservation and ischemia/reperfusion-injury in rats. Kidney Int 2006: 70: 321.
42. Schnuelle P, Gottmann U, Hoeger S et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA 2009: 302: 1067.
43. Tullius SG, Nieminen-Kelha M, Buelow R et al. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 2002: 74: 591.
44. Martins PN, Reutzel-Selke A, Jurisch A et al. Induction of carbon monoxide in donor animals prior to organ procurement reduces graft immunogenicity and inhibits chronic allograft dysfunction. Transplantation 2006: 82: 938.
45. Martins PN, Reuzel-Selke A, Jurisch A et al. Induction of carbon monoxide in the donor reduces graft immunogenicity and chronic graft deterioration. Transplant Proc 2005a: 37: 379.
46. Kotsch K, Martins PN, Klemz R et al. Heme oxygenase-1 ameliorates ischemia/reperfusion injury by targeting dendritic cell maturation and migration. Antioxid Redox Signal 2007: 9: 2049.
47. Caumartin Y, Stephen J, Deng JP et al. Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation. Kidney Int 2011: 79: 1080.
48. Martins PN, Kessler H, Jurisch A et al. Induction of heme oxygenase-1 in the donor reduces graft immunogenicity. Transplant Proc 2005b: 37: 384.
49. Holzen JP, August C, Bahde R et al. Influence of heme oxygenase-1 on microcirculation after kidney transplantation. J Surg Res 2008: 148: 126.
50. Damman J, Nijboer WN, Schuurs TA et al. Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation. Nephrol Dial Transplant 2011a: 26: 2345.
51. Damman J, Hoeger S, Boneschansker L et al. Targeting complement activation in brain-dead donors improves renal function after transplantation. Transpl Immunol 2011b: 24: 233.
52. Maio R, Sepodes B, Patel NS et al. Erythropoietin preserves the integrity and quality of organs for transplantation after cardiac death. Shock 2011: 35: 126.
53. Nijboer WN, Ottens PJ, van DA et al. Donor pretreatment with carbamylated erythropoietin in a brain death model reduces inflammation more effectively than erythropoietin while preserving renal function. Crit Care Med 2010: 38: 1155.
54. Nijboer WN, Schuurs TA, van der Hoeven JA et al. Effects of brain death on stress and inflammatory response in the human donor kidney. Transplant Proc 2005: 37: 367.
55. Nijboer WN, Schuurs TA, van der Hoeven JA et al. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation 2004: 78: 978.
56. Schuurs TA, Gerbens F, van der Hoeven JA et al. Distinct transcriptional changes in donor kidneys upon brain death induction in rats: insights in the processes of brain death. Am J Transplant 2004: 4: 1972.
57. Stangl M, Zerkaulen T, Theodorakis J et al. Influence of brain death on cytokine release in organ donors and renal transplants. Transplant Proc 2001: 33: 1284.
58. Eltzschig HK, Eckle T. Ischemia and reperfusion-from mechanism to translation. Nat Med 2011: 17: 1391.
59. Kuecuek O, Mantouvalou L, Klemz R et al. Significant reduction of proinflammatory cytokines by treatment of the brain-dead donor. Transplant Proc 2005: 37: 387.
60. Kainz A, Wilflingseder J, Mitterbauer C et al. Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial. Ann Intern Med 2010: 153: 222.
61. Chen L, Xu D, Gao Y et al. Effect of donor JNK signal transduction inhibition on transplant outcome in brain dead rat model. Inflammation 2012: 35: 122.
62. Shihab FS, Bennett WM, Andoh TF. Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation. Transplantation 2009: 87: 326.
63. Cicora F, Roberti J, Vasquez D et al. Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model. Clin Exp Immunol 2012: 167: 169.
64. Martinez-Palli G, Hirose R, Liu T et al. Donor pre-treatment with everolimus or cyclosporine does not reduce ischaemia-reperfusion injury in a rat kidney transplant model. Nephrol Dial Transplant 2011: 26: 1813.
65. Shihab FS, Bennett WM, Andoh TF. Role of cellular cholesterol in pharmacologic preconditioning with cyclosporine in experimental kidney transplantation. Am J Nephrol 2010: 31: 134.
66. Oesterwitz H, Scholz D, Kaden J, Mebel M. Prolongation of rat renal allograft survival time by donor pretreatment with 8-methoxypsoralen and longwave ultraviolet irradiation of the graft (PUVA therapy). Urol Res 1985: 13: 95.
67. Oesterwitz H, Kaden J, Scholz D, Mrochen H, Mebel M. Synergistic effect of donor pretreatment with 8-methoxypsoralen and ultraviolet irradiation of the graft plus azathioprine and prednisolone therapy in prolonging rat renal allograft survival. Urol Res 1986: 14: 21.
68. Oesterwitz H, Kaden J, Schneider W, Schirrow R, Scholz D. Synergistic effect of photochemical donor pretreatment and cyclosporin therapy of the recipient on rat renal allograft survival. Nephrol Dial Transplant 1987a: 2: 42.
69. Kaden J, Oesterwitz H, Schirrow R. Effects of photochemical donor pretreatment on the pattern of dog renal allograft infiltrating cells. Urol Res 1989: 17: 131.
70. Oesterwitz H, Scholz D, Kaden J et al. Photochemical donor pretreatment in clinical kidney transplantation-preliminary report. Urol Res 1987b: 15: 211.
71. Fuller TF, Serkova N, Niemann CU, Freise CE. Influence of donor pretreatment with N-acetylcysteine on ischemia/reperfusion injury in rat kidney grafts. J Urol 2004: 171: 1296.
72. Li Z, Nickkholgh A, Yi X et al. Melatonin protects kidney grafts from ischemia/reperfusion injury through inhibition of NF-kB and apoptosis after experimental kidney transplantation. J Pineal Res 2009: 46: 365.
73. Guan X, Dei-Anane G, Liang R et al. Donor preconditioning with taurine protects kidney grafts from injury after experimental transplantation. J Surg Res 2008: 146: 127.
74. Guan X, Dei-Anane G, Bruns H et al. Danshen protects kidney grafts from ischemia/reperfusion injury after experimental transplantation. Transpl Int 2009: 22: 232.
75. Hoeger S, Bergstraesser C, Selhorst J et al. Modulation of brain dead induced inflammation by vagus nerve stimulation. Am J Transplant 2010: 10: 477.
76. Gottmann U, Brinkkoetter PT, Hoeger S et al. Atorvastatin donor pretreatment prevents ischemia/reperfusion injury in renal transplantation in rats: possible role for aldose-reductase inhibition. Transplantation 2007: 84: 755.
77. Stepkowski SM, Wang ME, Condon TP et al. Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides. Transplantation 1998: 66: 699.
78. Fuller TF, Rose F, Singleton KD et al. Glutamine donor pretreatment in rat kidney transplants with severe preservation reperfusion injury. J Surg Res 2007: 140: 77.
79. Montazeri K, Vakily M, Honarmand A et al. Short-time intermittent preexposure of living human donors to hyperoxia improves renal function in early posttransplant period: a double-blind randomized clinical trial. J Transplant 2011: 2011: 204843.
80. Wahhabaghai H, Rasoulian B, Esmaili M et al. Hyperoxia-induced protection against rat's renal ischemic damage: relation to oxygen exposure time. Ren Fail 2009: 31: 514.
81. Rasoulian B, Mohammadhosseniakbari H, Kadkhodaee M et al. Preconditioning with oxygen attenuates rat renal ischemia-reperfusion injury. J Surg Res 2008: 146: 282.
82. Redaelli CA, Tien YH, Kubulus D et al. Hyperthermia preconditioning induces renal heat shock protein expression, improves cold ischemia tolerance, kidney graft function and survival in rats. Nephron 2002: 90: 489.
83. Redaelli CA, Wagner M, Kulli C et al. Hyperthermia-induced HSP expression correlates with improved rat renal isograft viability and survival in kidneys harvested from non-heart-beating donors. Transpl Int 2001: 14: 351.
84. Feng S. Donor intervention and organ preservation: where is the science and what are the obstacles? Am J Transplant 2010: 10: 1155.
85. Yang X, Qin L, Liu J, Tian L, Qian H. 17beta-Estradiol protects the liver against cold ischemia/reperfusion injury through the Akt kinase pathway. J Surg Res 2012: 178: 996.
86. Chin JT, Troke JJ, Kimura N et al. A novel cardioprotective agent in cardiac transplantation: metformin activation of AMP-activated protein kinase decreases acute ischemia-reperfusion injury and chronic rejection. Yale J Biol Med 2011: 84: 423.
87. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects: Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964 and amended by the: 9th WMA General Assembly, Seoul, Korea, October 2008.
88. Rey MM, Ware LB, Matthay MA et al. Informed consent in research to improve the number and quality of deceased donor organs. Crit Care Med 2011: 39: 280.
89. Pentz RD, Cohen CB, Wicclair M et al. Ethics guidelines for research with the recently dead. Nat Med 2005: 11: 1145.
90. Guesde R, Barrou B, Leblanc I et al. Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Lancet 1998: 352: 1178.
91. Abt PL, Marsh CL, Dunn TB et al. Challenges to research and innovation to optimize deceased donor organ quality and quantity. Am J Transplant 2013: 13: 1400.